China National Medicines Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.027x

China National Medicines Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, China National Medicines Corp Ltd (600511) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-540.00 Million ≈ $-79.02 Million USD) by net assets (CN¥19.93 Billion ≈ $2.92 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of China National Medicines Corp Ltd (2001–2024)

Cash flow conversion efficiency of China National Medicines Corp Ltd from 2001 to 2024. This chart illustrates how China National Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600511 share price today for real-time trading data and today's change.

China National Medicines Corp Ltd Cash Flow Conversion Ratio Explained

China National Medicines Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

China National Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China National Medicines Corp Ltd ranked by their cash flow conversion efficiency. Also see China National Medicines Corp Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Catcher Technology Co Ltd TW:2474	0.011x
Sigma Advanced Systems Limited NSE:MEGASOFT	-0.777x
Magnite Inc NASDAQ:MGNI	0.199x
Ideaya Biosciences Inc NASDAQ:IDYA	-0.136x
Inner Mongolia Yuan Xing Energy Co Ltd SHE:000683	0.104x
Avicopter PLC SHG:600038	-0.092x
SUNRISE N SW:SUNN	-0.006x
Azelis Group NV BR:AZE	0.020x

Annual Cash Flow Conversion Efficiency for China National Medicines Corp Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of China National Medicines Corp Ltd from 2001 to 2024. Review cash generation quality of China National Medicines Corp Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥18.98 Billion ≈ $2.78 Billion	CN¥1.66 Billion ≈ $242.78 Million	0.087x	-43.78%
2023-12-31	CN¥17.53 Billion ≈ $2.57 Billion	CN¥2.73 Billion ≈ $399.00 Million	0.156x	+2.97%
2022-12-31	CN¥15.86 Billion ≈ $2.32 Billion	CN¥2.40 Billion ≈ $350.48 Million	0.151x	+10.76%
2021-12-31	CN¥14.36 Billion ≈ $2.10 Billion	CN¥1.96 Billion ≈ $286.44 Million	0.136x	+37.17%
2020-12-31	CN¥13.09 Billion ≈ $1.92 Billion	CN¥1.30 Billion ≈ $190.48 Million	0.099x	-31.95%
2019-12-31	CN¥12.16 Billion ≈ $1.78 Billion	CN¥1.78 Billion ≈ $259.89 Million	0.146x	+57.88%
2018-12-31	CN¥10.61 Billion ≈ $1.55 Billion	CN¥981.65 Million ≈ $143.65 Million	0.093x	-18.57%
2017-12-31	CN¥9.46 Billion ≈ $1.38 Billion	CN¥1.07 Billion ≈ $157.23 Million	0.114x	-22.81%
2016-12-31	CN¥4.02 Billion ≈ $587.79 Million	CN¥591.25 Million ≈ $86.52 Million	0.147x	+17.49%
2015-12-31	CN¥3.51 Billion ≈ $514.25 Million	CN¥440.29 Million ≈ $64.43 Million	0.125x	+47.68%
2014-12-31	CN¥2.58 Billion ≈ $377.65 Million	CN¥218.94 Million ≈ $32.04 Million	0.085x	+0.39%
2013-12-31	CN¥2.20 Billion ≈ $321.31 Million	CN¥185.56 Million ≈ $27.15 Million	0.085x	-15.00%
2012-12-31	CN¥1.87 Billion ≈ $273.56 Million	CN¥185.87 Million ≈ $27.20 Million	0.099x	+141.13%
2011-12-31	CN¥1.53 Billion ≈ $224.31 Million	CN¥-370.56 Million ≈ $-54.22 Million	-0.242x	-202.04%
2010-12-31	CN¥1.34 Billion ≈ $196.55 Million	CN¥318.21 Million ≈ $46.56 Million	0.237x	+0.56%
2009-12-31	CN¥1.08 Billion ≈ $158.49 Million	CN¥255.18 Million ≈ $37.34 Million	0.236x	-5.77%
2008-12-31	CN¥868.25 Million ≈ $127.05 Million	CN¥217.10 Million ≈ $31.77 Million	0.250x	+128.39%
2007-12-31	CN¥725.96 Million ≈ $106.23 Million	CN¥79.48 Million ≈ $11.63 Million	0.109x	-46.75%
2006-12-31	CN¥590.99 Million ≈ $86.48 Million	CN¥121.50 Million ≈ $17.78 Million	0.206x	+16.24%
2005-12-31	CN¥521.33 Million ≈ $76.29 Million	CN¥92.20 Million ≈ $13.49 Million	0.177x	+75.64%
2004-12-31	CN¥488.38 Million ≈ $71.47 Million	CN¥49.18 Million ≈ $7.20 Million	0.101x	+8868.91%
2003-12-31	CN¥468.65 Million ≈ $68.58 Million	CN¥526.15K ≈ $76.99K	0.001x	-97.05%
2002-12-31	CN¥399.62 Million ≈ $58.48 Million	CN¥15.19 Million ≈ $2.22 Million	0.038x	+143.44%
2001-12-31	CN¥134.77 Million ≈ $19.72 Million	CN¥-11.80 Million ≈ $-1.73 Million	-0.088x	--

About China National Medicines Corp Ltd

SHG:600511 China Medical Distribution

Market Cap

$3.08 Billion

CN¥21.05 Billion CNY

Market Cap Rank

#4667 Global

#694 in China

Share Price

CN¥27.90

Change (1 day)

+0.43%

52-Week Range

CN¥25.70 - CN¥30.74

All Time High

CN¥57.66